Unknown

Dataset Information

0

Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm.

ABSTRACT:

SUBMITTER: Salisbury RA 

PROVIDER: S-EPMC7880652 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme.
| S-EPMC5013497 | biostudies-literature
Unknown Physician perceptions of drug utilization management: Results of a national survey.
| S-EPMC9488785 | biostudies-literature
Unknown Deletion of Ptpn1 induces myeloproliferative neoplasm.
| S-EPMC5967380 | biostudies-literature
Unknown Perceived benefits and barriers to implementing precision preventive care: Results of a national physician survey.
| S-EPMC10620193 | biostudies-literature
Unknown Burnout and long COVID among the UK nephrology workforce: results from a national survey investigating the impact of COVID-19 on working lives.
| S-EPMC8754810 | biostudies-literature
Unknown Patient-reported factors associated with avoidance of in-person care during the COVID-19 pandemic: Results from a national survey.
| S-EPMC9355185 | biostudies-literature
Unknown When should electronic medical records reminders for cancer screening stop?-Results from a national physician survey.
| S-EPMC10935591 | biostudies-literature
Unknown Low-dose methotrexate in myeloproliferative neoplasm models.
| S-EPMC5685234 | biostudies-literature
Unknown Mutational landscape of myelodysplastic/myeloproliferative neoplasm-unclassifiable.
| S-EPMC6236463 | biostudies-literature
Unknown Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19.
| S-EPMC9538387 | biostudies-literature